info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Stem Cell Reconstructive Companies

Stem Cell Reconstructive companies lead in the development of regenerative medicine solutions. They focus on harnessing the potential of stem cells for reconstructive purposes, aiming to repair and replace damaged tissues. These companies play a crucial role in advancing innovative therapies for a range of medical conditions.


 

Latest Stem Cell Reconstructive Companies Update


Asterias Biotherapeutics Receives IND Approval for Autologous Mesenchymal Stem Cell (MSC) Treatment for Cartilage Reconstruction: This December 2023 development paves the way for clinical trials on this promising therapy for knee cartilage damage.


Osiris Therapeutics Reports Positive Phase 2a Results for Prochymal in Osteoarthritis: December 2023 news further validates the potential of Prochymal, Osiris' mesenchymal stem cell therapy, for treating knee osteoarthritis.


Regen Therapeutics Completes Enrollment for Phase 2 Trial of HRPT-128 for Rotator Cuff Tears: This January 2024 milestone advances the development of Regen's adipose-derived stem cell therapy for this common shoulder injury.


Cyto Therapeutics Partners with Mayo Clinic for Stem Cell Research in Orthopedic Surgery collaboration will focus on developing new stem cell therapies for various musculoskeletal conditions.


NuVasive Invests in Orthox Regenerative Medicine strategic investment in December 2023 strengthens NuVasive's foothold in the regenerative medicine space for spine and orthopedic applications.


Medi-post and Anterogen Form Joint Venture for Development and Commercialization of Stem Cell Therapies partnership combines Medi-post's expertise in cell processing with Anterogen's stem cell platform to accelerate clinical development and market access.


List of Stem Cell Reconstructive Key Companies in the Market



  • Cynata (Australia),

  • Celyad (Belgium),

  • Capricor Therapeutics (Canada),

  • Micronit Microfluidics (Netherlands),

  • TAKARA BIO INC.(Japan),

  • Tigenix (Belgium) Baxter (US),

  • Cytori Therapeutics Inc. (US),

  • Eleveflow (France),

  • Mesoblast Ltd. (Australia),

  • NuVasive Inc. (US),

  • Osiris Therapeutics, Inc. (US)

  • Pfizer Inc. (US)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.